Schisanhenol B
Schisanhenol B is one of the active ingredients of schisandra chinensis. Schisanhenol B is a tyrosinase inhibitor. Schisanhenol B has good binding activity with PIK3CG and can be used in the study of heart failure.
For research use only. We do not sell to patients.
- CAS No.: 102681-52-7
- Formula: C22H26O6
- Molecular Weight:386.44
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
>10 μM
Compound: 11
|
Cytotoxicity against human A549 cells after 3 days by MTT assay
Cytotoxicity against human A549 cells after 3 days by MTT assay
|
[PMID: 23738539] |
| HCT-116 | IC50 |
55.38 μM
Compound: GM
|
Antiproliferative activity against human HCT-116 cells incubated for 24 hrs by alamar blue assay
Antiproliferative activity against human HCT-116 cells incubated for 24 hrs by alamar blue assay
|
[PMID: 34038111] |
| HeLa | IC50 |
17.15 μM
Compound: GM
|
Antiproliferative activity against human HeLa cells assessed as increase in miR-21 biogenesis level measured after 24 hrs by luciferase assay
Antiproliferative activity against human HeLa cells assessed as increase in miR-21 biogenesis level measured after 24 hrs by luciferase assay
|
[PMID: 34038111] |
| HeLa | IC50 |
32.83 μM
Compound: GM
|
Antiproliferative activity against human HeLa cells incubated for 24 hrs by alamar blue assay
Antiproliferative activity against human HeLa cells incubated for 24 hrs by alamar blue assay
|
[PMID: 34038111] |
| HepG2 | IC50 |
27.26 μM
Compound: GM
|
Antiproliferative activity against human HepG2 cells incubated for 24 hrs by alamar blue assay
Antiproliferative activity against human HepG2 cells incubated for 24 hrs by alamar blue assay
|
[PMID: 34038111] |
| Huh-7 | IC50 |
32.23 μM
Compound: GM
|
Antiproliferative activity against human Huh-7 cells incubated for 24 hrs by alamar blue assay
Antiproliferative activity against human Huh-7 cells incubated for 24 hrs by alamar blue assay
|
[PMID: 34038111] |
| MCF7 | IC50 |
>10 μM
Compound: 11
|
Cytotoxicity against human MCF7 cells after 3 days by MTT assay
Cytotoxicity against human MCF7 cells after 3 days by MTT assay
|
[PMID: 23738539] |
| MDA-MB-231 | IC50 |
56.61 μM
Compound: GM
|
Antiproliferative activity against human MDA-MB-231 cells incubated for 24 hrs by alamar blue assay
Antiproliferative activity against human MDA-MB-231 cells incubated for 24 hrs by alamar blue assay
|
[PMID: 34038111] |
| MHCC97 | IC50 |
24.75 μM
Compound: GM
|
Antiproliferative activity against human MHCC97 cells incubated for 24 hrs by alamar blue assay
Antiproliferative activity against human MHCC97 cells incubated for 24 hrs by alamar blue assay
|
[PMID: 34038111] |
| NB-4 | IC50 |
>10 μM
Compound: 11
|
Cytotoxicity against human NB4 cells after 3 days by MTT assay
Cytotoxicity against human NB4 cells after 3 days by MTT assay
|
[PMID: 23738539] |
| PC-3 | IC50 |
>10 μM
Compound: 11
|
Cytotoxicity against human PC3 cells after 3 days by MTT assay
Cytotoxicity against human PC3 cells after 3 days by MTT assay
|
[PMID: 23738539] |
| SH-SY5Y | IC50 |
>10 μM
Compound: 11
|
Cytotoxicity against human SH-SY5Y cells after 3 days by MTT assay
Cytotoxicity against human SH-SY5Y cells after 3 days by MTT assay
|
[PMID: 23738539] |
| SK-HEP1 | IC50 |
20.56 μM
Compound: GM
|
Antiproliferative activity against human SK-HEP1 cells incubated for 24 hrs by alamar blue assay
Antiproliferative activity against human SK-HEP1 cells incubated for 24 hrs by alamar blue assay
|
[PMID: 34038111] |
Chemical Information
-
CAS No. 102681-52-7
-
Molecular Weight 386.44
-
Formula C22H26O6
-
SMILES
OC1=C(C(OC)=CC2=C1C3=C(C4=C(C=C3C[C@@H]([C@@H](C2)C)C)OCO4)OC)OC
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Cardiovascular Diseases
Cardiovascular disease can be modeled as maladaptive cardiac remodeling, where ischemic injury or pressure overload activates inflammatory signaling, fibroblast activation, extracellular-matrix deposition, cardiomyocyte hypertrophy, vascular remodeling, and progressive ventricular dysfunction. The TGF-β/SMAD axis is a central profibrotic pathway after myocardial injury and pressure overload, while innate immune and cytokine pathways regulate leukocyte recruitment, scar formation, and adverse remodeling. Key unresolved questions include which inflammatory signals are reparative versus harmful, when fibrosis is protective versus maladaptive, and whether pathway inhibition improves function without weakening necessary infarct healing or compensatory remodeling.
Purity & Documentation
References
[1]. Wen S, et al. Investigating the Mechanism of Action of Schisandra chinensis Combined with Coenzyme Q10 in the Treatment of Heart Failure Based on PI3K-AKT Pathway. Drug Des Devel Ther. 2023 Mar 27;17:939-957. [Content Brief]
[2]. Sobstyl E, et al. Chromatographic and Biological Screening of Chosen Species of Schisandraceae Family: Schisandra chinensis, S. rubriflora, S. sphenanthera, S. henryi and Kadsura japonica. Chem Biodivers. 2023 Oct;20(10):e202300741. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)